Abstract:'Reactive oxygen species' (ROS) is an umbrella term for an array of derivatives of molecular oxygen that occur as a normal attribute of aerobic life. Elevated formation of the different ROS leads to molecular damage, denoted as 'oxidative distress'. Here we focus on ROS at physiological levels and their central role in redox signalling via different post-translational modifications, denoted as 'oxidative eustress'. Two species, hydrogen peroxide (H2O2) and the superoxide anion radical (O2·−), are key redox signalling agents generated under the control of growth factors and cytokines by more than 40 enzymes, prominently including NADPH oxidases and the mitochondrial electron transport chain. At the low physiological levels in the nanomolar range, H2O2 is the major agent signalling through specific protein targets, which engage in metabolic regulation and stress responses to support cellular adaptation to a changing environment and stress. In addition, several other reactive species are involved in redox signalling, for instance nitric oxide, hydrogen sulfide and oxidized lipids. Recent methodological advances permit the assessment of molecular interactions of specific ROS molecules with specific targets in redox signalling pathways. Accordingly, major advances have occurred in understanding the role of these oxidants in physiology and disease, including the nervous, cardiovascular and immune systems, skeletal muscle and metabolic regulation as well as ageing and cancer. In the past, unspecific elimination of ROS by use of low molecular mass antioxidant compounds was not successful in counteracting disease initiation and progression in clinical trials. However, controlling specific ROS-mediated signalling pathways by selective targeting offers a perspective for a future of more refined redox medicine. This includes enzymatic defence systems such as those controlled by the stress-response transcription factors NRF2 and nuclear factor-κB, the role of trace elements such as selenium, the use of redox drugs and the modulation of environmental factors collectively known as the exposome (for example, nutrition, lifestyle and irradiation).

Modulation of redox signal transduction pathways in the treatment of cancer

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

Modulation of oxidative stress as an anticancer strategy

Targeting ROS in cancer: rationale and strategies

Modulation of reactive oxygen species in cancers: recent advances

Targeting the Redox Landscape in Cancer Therapy

ROS signalling in the biology of cancer

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Ros Stress in Cancer Cells and Therapeutic Implications

Redox Potential of Antioxidants in Cancer Progression and Prevention

Metabolic Regulation of Redox Balance in Cancer

Redox control of the survival of healthy and diseased cells.

Modulation of redox homeostasis: A strategy to overcome cancer drug resistance

Modulating ROS to Overcome Multidrug Resistance in Cancer.

Redox regulation and its emerging roles in cancer treatment

Teaching the basics of reactive oxygen species and their relevance to cancer biology: Mitochondrial reactive oxygen species detection, redox signaling, and targeted therapies

Modulating Intracellular Oxidative Stress Via Engineered Nanotherapeutics

Cancer Cell Killing Via ROS: to Increase or Decrease, That is the Question

Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements

Redox Regulation of Cell Survival

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents